2022 ASCO Annual Meeting
June 3-7 | Join us at booth 3135 in Chicago at the 2022 ASCO Annual Meeting and Expo.
- Category:
- Past Events
News & Events
ESHG Conference 2022
JUNE 11–14, 2022 | Join us at the European Human Genetics Conference in Vienna
- Category:
- Past Events
74th Annual AAFS 2022 Annual Scientific Conference
February 21-25 | Join us at the annual conference to learn more about the exciting new advances in NGS and forensic science.
- Category:
- Past Events
HTG Names Renowned RNA Expert Dr. Robert Spitale to Therapeutics Scientific Advisory Board
TUCSON, Ariz. , Feb. 03, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed Robert Spitale , Ph.D., Associate Director and…
- Category:
- Press Releases
HTG Appoints Biopharmaceutical Industry VeteranChristopher Kiritsy to its Board of Directors
Brings Significant Operational Experience in Building Therapeutic Drug Development Businesses TUCSON, Ariz. , Jan. 28, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide…
- Category:
- Press Releases
HTG Molecular Diagnostics Announces Certain Preliminary 2021Unaudited Financial Results
Preliminary full year 2021 unaudited revenue of $8.9 million Cash, cash equivalents and short-term marketable securities of $21.9 million as of December 31, 2021 TUCSON, Ariz. , Jan. 06, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose…
- Category:
- Press Releases
HTG Completes HTP Product Next-Phase Development Milestone
Expands Potential Market and Study Opportunities for HTG Transcriptome Panel TUCSON, Ariz. , Dec. 22, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology,…
- Category:
- Press Releases
HTG Expands Therapeutics Scientific Advisory Board With Addition of Dr. Jerald Radich
Renowned Physician-Scientist Brings Significant Expertise as a Pioneer in the Fields of Leukemia Research and Molecular Genetics TUCSON, Ariz. , Dec. 16, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its…
- Category:
- Press Releases
HTG Overview Video
HTG’s proprietary RNA technologies are designed to help better understand disease and treatment options for patients and to unlock a disruptive approach to drug discovery.
HTG Announces Major Sales Milestone for HTG Transcriptome Panel
Recognizes More Than $1 Million of HTP Revenue Through November 2021 TUCSON, Ariz. , Dec. 09, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced…
- Category:
- Press Releases
HTG and Icahn School of Medicine at Mount Sinai Announce Bladder Cancer Research Collaboration
HTG’s Innovative Transcriptome Panel Technology to be Leveraged in Retrospective Studies TUCSON, Ariz. , Nov. 17, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling…
- Category:
- Press Releases
HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TUCSON, Ariz. , Nov. 15, 2021 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that, on November 9, 2021 the Compensation Committee of the…
- Category:
- Press Releases
Page last updated March 20, 2023